Allogene Therapeutics, Inc. (ALLO)
3.05
+0.33
(+12.13%)
USD |
NASDAQ |
Apr 13, 16:00
2.82
-0.23
(-7.54%)
After-Hours: 20:00
Allogene Therapeutics Cash from Investing (TTM) : 95.56M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | -34.32M |
| Inovio Pharmaceuticals, Inc. | 14.04M |
| Vaxart, Inc. | 16.63M |
| Capricor Therapeutics, Inc. | 97.48M |
| Agenus, Inc. | 1.194M |